December 4, 2009 - Breast-Specific Gamma Imaging (BSGI) is a molecular breast imaging technique increasingly being used in the diagnostic workup of patients with indeterminate mammograms and has demonstrated the ability to detect cancers missed by mammography and ultrasound. However, broad acceptance of this imaging technique has been limited due to the inability to perform minimally invasive, image-guided biopsy procedures under this modality.

One technique that may break through this limitation is stereotactic BSGI needle guidance, according to findings presented by Cynthia Lorino, M.D., of the Montgomery Breast Center of Montgomery, Ala. at the annual meeting of the Radiological Society of North America (RSNA).

In this study, the GammaL c device, an accessory to the Dilon 6800 Gamma Camera, provided accurate lesion localization and facilitated needle-guided biopsy. The stereotactic lesion localization system was developed to allow BSGI-guided, vacuum-assisted needle biopsy. The purpose of the study was to examine the clinical viability of the system.

Patients who were routinely scheduled for a needle biopsy based on clinical findings and also had a focal abnormality on BSGI were invited to participate in the clinical trial of the GammaL c system. In the study, 17 patients of variable breast sizes patients with lesions ranging from 4 mm to 70 mm underwent BSGI-guided vacuum-assisted needle biopsies. All of the biopsy results were concordant with known Sestamibi avid pathologies successfully demonstrating the clinical accuracy of this guidance system. In addition, in some cases, both the BSGI diagnostic examination and Gamma-Guided biopsy were conducted in a single day using only one administration of Sestamibi.

The authors wrote in their conclusion, "The GammaLoc stereotactic biopsy apparatus provides an accurate, convenient means for conducting vacuum-assisted needle biopsy of breast abnormalities."

The GammaL c accessory is pending FDA clearance.

For more information: www.dilon.com


Related Content

News | Breast Biopsy Systems

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

Time July 07, 2021
arrow
News | Breast Imaging

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...

Time January 04, 2021
arrow
News | Prostate Cancer

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.

Time August 20, 2019
arrow
News | Biopsy Systems

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.

Time March 29, 2019
arrow
Technology | Interventional Radiology

The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

Time February 20, 2019
arrow
News | Prostate Cancer

Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.

Time February 12, 2019
arrow
News | Breast Biopsy Systems

A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology

Time January 17, 2019
arrow
Videos | Radiation Oncology

Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his ...

Time November 07, 2018
arrow
News | Radiation Oncology

October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to ...

Time October 30, 2018
arrow
Technology | Breast Biopsy Systems

Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.

Time October 03, 2018
arrow
Subscribe Now